NGNE
Neurogene Inc.
Price Chart
Latest Quote
$30.86
-1.39 (-4.31%)
Current Price
| Previous Close | $32.25 |
| Open | $31.97 |
| Day High | $32.62 |
| Day Low | $30.80 |
| Volume | 116,367 |
Stock Information
| Shares Outstanding | 15.80M |
| Total Debt | $9.13M |
| Cash Equivalents | $243.18M |
| Net Income | $-98.64M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $487.65M |
| EPS (TTM) | $-4.55 |
| Exchange | NGM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $253.59M |
| Income | $-98.64M |
| Book/sh | $15.23 |
| Cash/sh | $15.39 |
| Employees | 131 |
Financial Ratios
| Quick Ratio | 12.90 |
| Current Ratio | 13.08 |
| Debt/Eq | 3.84 |
Returns & Margins
| ROA | -23.91% |
| ROE | -37.25% |
Ownership
| Insider Ownership | 8.83% |
| Institutional Ownership | 110.56% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -5.52 |
| P/B | 2.03 |
Analyst Data
| Recommendation | strong_buy |
| Target Price | $80.00 |
Technical Indicators
| SMA20 | $28.59 |
| SMA50 | $28.07 |
| SMA200 | $23.26 |
| RSI | 69.50 |
| ATR | 2.0582 |
| Shares Float | 6.01M |
| Short Float | 28.02% |
| Short Ratio | 24.70 |
| Volatility | 2.04 |
| Rel Volume | 0.74 |
Performance History
| Week | +3.35% |
| Month | +11.77% |
| Quarter | +59.40% |
| 6 Months | +60.06% |
| YTD | +53.08% |
| Year | +73.76% |
| 3 Years | +108.51% |
| 5 Years | -84.93% |
| 10 Years | -76.26% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-23 | $30.86 | 116,367 |
| 2026-06-22 | $32.25 | 175,500 |
| 2026-06-18 | $31.53 | 308,900 |
| 2026-06-17 | $30.79 | 250,900 |
| 2026-06-16 | $29.35 | 160,700 |
| 2026-06-15 | $29.86 | 116,200 |
| 2026-06-12 | $29.10 | 112,500 |
| 2026-06-11 | $29.00 | 127,100 |
| 2026-06-10 | $28.01 | 237,400 |
| 2026-06-09 | $28.81 | 549,600 |
| 2026-06-08 | $28.60 | 166,200 |
| 2026-06-05 | $26.49 | 67,400 |
| 2026-06-04 | $27.48 | 46,200 |
| 2026-06-03 | $26.22 | 87,600 |
| 2026-06-02 | $26.14 | 107,400 |
| 2026-06-01 | $27.54 | 102,200 |
| 2026-05-29 | $28.34 | 98,400 |
| 2026-05-28 | $27.50 | 63,000 |
| 2026-05-27 | $26.87 | 97,700 |
| 2026-05-26 | $27.10 | 156,100 |
About Neurogene Inc.
Neurogene Inc., a clinical stage biotechnology company, develops genetic medicines for rare neurological diseases. The company's product candidates include NGN-401 that is packaged in an adeno-associated virus 9, which is in Phase 1/2 clinical trial for the treatment of Rett syndrome; and NGN-101, a conventional gene therapy candidate that is in Phase 1/2 clinical trial to treat CLN5 Batten disease. It has a license agreement with The University of Edinburgh, Virovek, Inc., Sigma-Aldrich Co. LLC., and Leland Stanford Junior University. The company was founded in 2018 and is headquartered in New York, New York.
đ° Latest News
We Think Neurogene (NASDAQ:NGNE) Can Afford To Drive Business Growth
Simply Wall St. âĸ 2026-05-05T11:37:58Z
Neurogene: Q4 Earnings Snapshot
Associated Press Finance âĸ 2026-03-24T11:46:32ZNeurogene CEO Details NGN-401 Rett Trial, FDA Alignment, and Key 2026 Catalysts at Conference
MarketBeat âĸ 2026-03-21T07:02:07Z
Block upgraded, Duolingo downgraded: Wall Street's top analyst calls
The Fly âĸ 2026-02-27T14:50:03Z
Here Are Fridayâs Top Wall Street Analyst Research Calls: Block, Costco, Dollar Tree, Duolingo, Palantir Technologies, Southwest Airlines, Synopsis, Warner Bros. Discovery, and More
24/7 Wall St. âĸ 2026-02-27T12:59:45Z
Neurogene Maps NGN-401 Pivotal Rett Timeline, Mid-2026 Data Update at Guggenheim Summit
MarketBeat âĸ 2026-02-14T14:05:47Z
Companies Like Neurogene (NASDAQ:NGNE) Are In A Position To Invest In Growth
Simply Wall St. âĸ 2025-11-26T10:51:22Z
Neurogene: Q3 Earnings Snapshot
Associated Press Finance âĸ 2025-11-13T22:21:58ZNeurogene: Q2 Earnings Snapshot
Associated Press Finance âĸ 2025-08-11T21:55:20ZBullish Neurogene Insiders Loaded Up On US$1.46m Of Stock
Simply Wall St. âĸ 2025-07-30T10:14:47Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $925,000 | $0 | $0 |
| Operating Revenue | $0 | $925,000 | $0 | $0 |
| Expenses | ||||
| Interest Expense | $5,000 | $12,000 | $12,000 | $2,000 |
| Total Expenses | $103,328,000 | $83,530,000 | $55,583,000 | $56,517,000 |
| Other Income Expense | $1,435,000 | $-994,000 | $16,327,000 | $-7,000 |
| Other Non Operating Income Expenses | $1,435,000 | $-994,000 | $-28,000 | $-7,000 |
| Net Non Operating Interest Income Expense | $11,542,000 | $8,455,000 | $2,939,000 | $1,335,000 |
| Interest Expense Non Operating | $5,000 | $12,000 | $12,000 | $2,000 |
| Operating Expense | $103,328,000 | $83,530,000 | $55,583,000 | $56,517,000 |
| General And Administrative Expense | $28,317,000 | $22,613,000 | $11,189,000 | $9,012,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-90,351,000 | $-75,144,000 | $-36,317,000 | $-55,189,000 |
| Net Interest Income | $11,542,000 | $8,455,000 | $2,939,000 | $1,335,000 |
| Interest Income | $11,547,000 | $8,467,000 | $2,951,000 | $1,337,000 |
| Normalized Income | $-90,351,000 | $-75,144,000 | $-52,672,000 | $-55,189,000 |
| Net Income From Continuing And Discontinued Operation | $-90,351,000 | $-75,144,000 | $-36,317,000 | $-55,189,000 |
| Total Operating Income As Reported | $-103,328,000 | $-82,605,000 | $-55,583,000 | $-56,517,000 |
| Net Income Common Stockholders | $-90,351,000 | $-75,144,000 | $-36,317,000 | $-55,189,000 |
| Net Income | $-90,351,000 | $-75,144,000 | $-36,317,000 | $-55,189,000 |
| Net Income Including Noncontrolling Interests | $-90,351,000 | $-75,144,000 | $-36,317,000 | $-55,189,000 |
| Net Income Continuous Operations | $-90,351,000 | $-75,144,000 | $-36,317,000 | $-55,189,000 |
| Pretax Income | $-90,351,000 | $-75,144,000 | $-36,317,000 | $-55,189,000 |
| Interest Income Non Operating | $11,547,000 | $8,467,000 | $2,951,000 | $1,337,000 |
| Operating Income | $-103,328,000 | $-82,605,000 | $-55,583,000 | $-56,517,000 |
| Special Income Charges | - | $574,000 | $16,355,000 | $0 |
| Per Share | ||||
| Diluted EPS | $-4.24 | $-4.28 | $-73.83 | $-37.80 |
| Basic EPS | $-4.24 | $-4.28 | $-73.83 | $-37.80 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-87,254,000 | $-71,885,000 | $-49,363,000 | $-51,987,000 |
| Reconciled Depreciation | $3,092,000 | $3,247,000 | $3,297,000 | $3,200,000 |
| EBITDA (Bullshit earnings) | $-87,254,000 | $-71,885,000 | $-33,008,000 | $-51,987,000 |
| EBIT | $-90,346,000 | $-75,132,000 | $-36,305,000 | $-55,187,000 |
| Diluted Average Shares | $21,326,283 | $17,567,082 | $4,656,947 | $1,459,980 |
| Basic Average Shares | $21,326,283 | $17,567,082 | $491,867 | $1,459,980 |
| Diluted NI Availto Com Stockholders | $-90,351,000 | $-75,144,000 | $-36,317,000 | $-55,189,000 |
| Research And Development | $75,011,000 | $60,917,000 | $44,394,000 | $47,505,000 |
| Selling General And Administration | $28,317,000 | $22,613,000 | $11,189,000 | $9,012,000 |
| Other Gand A | $11,349,000 | $10,702,000 | $11,189,000 | $9,012,000 |
| Salaries And Wages | $16,968,000 | $11,911,000 | - | - |
| Total Unusual Items | - | $574,000 | $16,355,000 | $0 |
| Total Unusual Items Excluding Goodwill | - | $574,000 | $16,355,000 | $0 |
| Restructuring And Mergern Acquisition | - | $-574,000 | $-16,355,000 | $0 |
Fetched: 2026-06-19
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $264,887,000 | $310,375,000 | $186,024,000 | $-145,739,000 |
| Total Assets | $288,604,000 | $335,730,000 | $222,573,000 | $109,265,000 |
| Total Non Current Assets | $16,834,000 | $19,807,000 | $22,225,000 | $24,546,000 |
| Other Non Current Assets | $1,372,000 | $1,314,000 | $1,272,000 | - |
| Current Assets | $271,770,000 | $315,923,000 | $200,348,000 | $84,719,000 |
| Other Current Assets | $168,000 | $981,000 | $1,095,000 | $630,000 |
| Current Deferred Assets | $191,000 | $0 | - | - |
| Prepaid Assets | $1,938,000 | $1,889,000 | $1,496,000 | $1,078,000 |
| Receivables | $460,000 | $648,000 | $600,000 | $990,000 |
| Other Receivables | $460,000 | $648,000 | $600,000 | $990,000 |
| Cash Cash Equivalents And Short Term Investments | $269,013,000 | $312,405,000 | $197,157,000 | $82,021,000 |
| Cash And Cash Equivalents | $103,845,000 | $136,586,000 | $148,210,000 | $82,021,000 |
| Non Current Accounts Receivable | - | - | $98,000 | $87,000 |
| Notes Receivable | - | - | $48,947,000 | $0 |
| Debt | ||||
| Total Debt | $10,957,000 | $14,237,000 | $16,255,000 | $4,689,000 |
| Long Term Debt And Capital Lease Obligation | $7,255,000 | $10,147,000 | $13,373,000 | $3,987,000 |
| Current Debt And Capital Lease Obligation | $3,702,000 | $4,090,000 | $2,882,000 | $702,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $23,717,000 | $25,355,000 | $36,549,000 | $255,004,000 |
| Total Non Current Liabilities Net Minority Interest | $7,306,000 | $10,198,000 | $13,576,000 | $248,353,000 |
| Other Non Current Liabilities | $51,000 | $51,000 | $203,000 | - |
| Current Liabilities | $16,411,000 | $15,157,000 | $22,973,000 | $6,651,000 |
| Other Current Liabilities | $564,000 | $342,000 | $737,000 | $167,000 |
| Payables And Accrued Expenses | $7,073,000 | $6,383,000 | $13,382,000 | $2,425,000 |
| Payables | $1,953,000 | $1,336,000 | $2,596,000 | $625,000 |
| Accounts Payable | $1,953,000 | $1,336,000 | $2,596,000 | $625,000 |
| Equity | ||||
| Common Stock Equity | $264,887,000 | $310,375,000 | $186,024,000 | $-145,739,000 |
| Total Equity Gross Minority Interest | $264,887,000 | $310,375,000 | $186,024,000 | $-145,739,000 |
| Stockholders Equity | $264,887,000 | $310,375,000 | $186,024,000 | $-145,739,000 |
| Retained Earnings | $-352,649,000 | $-262,298,000 | $-187,154,000 | $-150,837,000 |
| Preferred Securities Outside Stock Equity | - | - | $0 | $244,366,000 |
| Other | ||||
| Ordinary Shares Number | $15,489,800 | $14,854,725 | $12,823,665 | $12,823,665 |
| Share Issued | $15,489,800 | $14,854,725 | $12,823,665 | $12,823,665 |
| Tangible Book Value | $264,887,000 | $310,375,000 | $186,024,000 | $-145,739,000 |
| Invested Capital | $264,887,000 | $310,375,000 | $186,024,000 | $-145,739,000 |
| Working Capital | $255,359,000 | $300,766,000 | $177,375,000 | $78,068,000 |
| Capital Lease Obligations | $10,957,000 | $14,237,000 | $16,255,000 | $4,689,000 |
| Total Capitalization | $264,887,000 | $310,375,000 | $186,024,000 | $-145,739,000 |
| Additional Paid In Capital | $617,536,000 | $572,673,000 | $373,178,000 | $5,098,000 |
| Capital Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Preferred Stock | $0 | $0 | $0 | - |
| Long Term Capital Lease Obligation | $7,255,000 | $10,147,000 | $13,373,000 | $3,987,000 |
| Current Capital Lease Obligation | $3,702,000 | $4,090,000 | $2,882,000 | $702,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $5,072,000 | $4,342,000 | $5,972,000 | $3,357,000 |
| Current Accrued Expenses | $5,120,000 | $5,047,000 | $10,786,000 | $1,800,000 |
| Net PPE | $15,462,000 | $18,493,000 | $20,953,000 | $24,546,000 |
| Accumulated Depreciation | $-14,109,000 | $-11,171,000 | $-8,009,000 | $-4,767,000 |
| Gross PPE | $29,571,000 | $29,664,000 | $28,962,000 | $29,313,000 |
| Leases | $15,418,000 | $15,396,000 | $15,376,000 | $15,298,000 |
| Construction In Progress | $324,000 | $1,308,000 | $234,000 | $252,000 |
| Other Properties | $13,514,000 | $12,656,000 | $13,065,000 | $13,474,000 |
| Machinery Furniture Equipment | $315,000 | $304,000 | $287,000 | $289,000 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $165,168,000 | $175,819,000 | $48,947,000 | $0 |
Fetched: 2026-06-19
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-78,356,000 | $-71,411,000 | $-51,743,000 | $-55,054,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-77,173,000 | $-70,603,000 | $-51,422,000 | $-52,824,000 |
| Cash Flow From Continuing Operating Activities | $-77,173,000 | $-70,603,000 | $-51,422,000 | $-52,824,000 |
| Investing Activities | ||||
| Capital Expenditure | $-1,183,000 | $-808,000 | $-321,000 | $-2,230,000 |
| Investing Cash Flow | $14,004,000 | $-125,261,000 | $25,637,000 | $-2,230,000 |
| Cash Flow From Continuing Investing Activities | $14,004,000 | $-125,261,000 | $25,637,000 | $-2,230,000 |
| Net Other Investing Changes | - | - | $20,958,000 | - |
| Financing Activities | ||||
| Issuance Of Capital Stock | $30,380,000 | $189,589,000 | $92,343,000 | $66,459,000 |
| Financing Cash Flow | $30,428,000 | $184,071,000 | $92,482,000 | $66,531,000 |
| Cash Flow From Continuing Financing Activities | $30,428,000 | $184,071,000 | $92,482,000 | $66,531,000 |
| Net Other Financing Charges | $-241,000 | $-7,142,000 | - | - |
| Net Common Stock Issuance | $30,380,000 | $189,589,000 | $92,343,000 | $0 |
| Common Stock Issuance | $30,380,000 | $189,589,000 | $92,343,000 | $0 |
| Net Preferred Stock Issuance | - | - | $0 | $66,459,000 |
| Preferred Stock Issuance | - | - | $0 | $66,459,000 |
| Other | ||||
| Repayment Of Debt | $-61,000 | $-52,000 | $-29,000 | $-1,000 |
| Interest Paid Supplemental Data | $5,000 | $12,000 | $12,000 | $2,000 |
| End Cash Position | $104,184,000 | $136,925,000 | $148,718,000 | $82,021,000 |
| Beginning Cash Position | $136,925,000 | $148,718,000 | $82,021,000 | $70,544,000 |
| Changes In Cash | $-32,741,000 | $-11,793,000 | $66,697,000 | $11,477,000 |
| Proceeds From Stock Option Exercised | $350,000 | $1,676,000 | $168,000 | $73,000 |
| Net Issuance Payments Of Debt | $-61,000 | $-52,000 | $-29,000 | $-1,000 |
| Net Long Term Debt Issuance | $-61,000 | $-52,000 | $-29,000 | $-1,000 |
| Long Term Debt Payments | $-61,000 | $-52,000 | $-29,000 | $-1,000 |
| Net Investment Purchase And Sale | $15,187,000 | $-124,453,000 | $5,000,000 | $0 |
| Sale Of Investment | $284,700,000 | $74,000,000 | $5,000,000 | $0 |
| Purchase Of Investment | $-269,513,000 | $-198,453,000 | $0 | - |
| Net PPE Purchase And Sale | $-1,183,000 | $-808,000 | $-321,000 | $-2,230,000 |
| Purchase Of PPE | $-1,183,000 | $-808,000 | $-321,000 | $-2,230,000 |
| Change In Working Capital | $268,000 | $-5,961,000 | $-4,023,000 | $-2,695,000 |
| Change In Other Current Liabilities | $-2,918,000 | $-2,573,000 | $-678,000 | $-610,000 |
| Change In Other Current Assets | $-58,000 | $-211,000 | $-764,000 | $0 |
| Change In Payables And Accrued Expense | $2,292,000 | $-2,850,000 | $-2,907,000 | $-2,801,000 |
| Change In Accrued Expense | $1,665,000 | $-2,773,000 | $-3,574,000 | $806,000 |
| Change In Payable | $627,000 | $-77,000 | $667,000 | $-3,607,000 |
| Change In Account Payable | $627,000 | $-77,000 | $667,000 | $-3,607,000 |
| Change In Prepaid Assets | $952,000 | $-327,000 | $326,000 | $716,000 |
| Other Non Cash Items | $51,000 | $1,263,000 | $-15,692,000 | $608,000 |
| Stock Based Compensation | $14,183,000 | $8,320,000 | $1,418,000 | $1,252,000 |
| Asset Impairment Charge | $120,000 | $91,000 | $0 | - |
| Amortization Of Securities | $-4,536,000 | $-2,419,000 | $-105,000 | $0 |
| Depreciation Amortization Depletion | $3,092,000 | $3,247,000 | $3,297,000 | $3,200,000 |
| Depreciation And Amortization | $3,092,000 | $3,247,000 | $3,297,000 | $3,200,000 |
| Depreciation | $3,092,000 | $3,247,000 | $3,297,000 | $3,200,000 |
| Net Income From Continuing Operations | $-90,351,000 | $-75,144,000 | $-36,317,000 | $-55,189,000 |
Fetched: 2026-06-19